DDHD1 Gene SPG28 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The DDHD1 Gene SPG28 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with hereditary spastic paraplegia type 28. This sophisticated genetic analysis utilizes cutting-edge next-generation sequencing technology to provide accurate, reliable results for patients and families affected by this progressive neurological condition.
What This Test Measures and Detects
This advanced genetic test specifically targets the DDHD1 gene, which plays a critical role in lipid metabolism and neuronal function. The test identifies:
- Pathogenic variants in the DDHD1 gene associated with SPG28
- Single nucleotide polymorphisms (SNPs) affecting gene function
- Insertions, deletions, and copy number variations
- Compound heterozygous mutations
- Autosomal recessive inheritance patterns
Who Should Consider This Test
This genetic test is particularly recommended for individuals experiencing:
- Progressive lower limb stiffness and weakness
- Difficulty walking or abnormal gait patterns
- Family history of hereditary spastic paraplegia
- Early-onset spasticity in childhood or adolescence
- Muscle cramps and urinary symptoms
- Unexplained neurological symptoms with family clustering
Clinical Benefits of Genetic Testing
Undergoing the DDHD1 Gene SPG28 test provides numerous advantages:
- Early Diagnosis: Enables prompt intervention and management strategies
- Family Planning: Provides crucial information for reproductive decisions
- Personalized Treatment: Guides targeted therapeutic approaches
- Prognostic Information: Helps predict disease progression and severity
- Genetic Counseling: Supports informed decision-making for at-risk family members
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists:
- Positive Result: Indicates the presence of pathogenic DDHD1 mutations, confirming SPG28 diagnosis
- Negative Result: Suggests absence of known SPG28-associated mutations in the DDHD1 gene
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Identifies individuals who carry one copy of the mutated gene
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures accessible testing for patients nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about hereditary spastic paraplegia affect your quality of life. Our DDHD1 Gene SPG28 NGS Genetic DNA Test provides the clarity you need to make informed healthcare decisions and plan for the future with confidence.
Ready to schedule your genetic test? Call us today at +1(267) 388-9828 or book your appointment online. Our genetic counselors are available to answer your questions and guide you through the testing process.
With a turnaround time of 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spots on FTA cards, we make genetic testing convenient and accessible. Take the first step toward understanding your genetic risk factors and protecting your neurological health.
